{"id":4224,"date":"2022-11-25T09:53:50","date_gmt":"2022-11-25T09:53:50","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/2022-international-hbv-meeting\/"},"modified":"2022-11-25T09:55:26","modified_gmt":"2022-11-25T09:55:26","slug":"2022-international-hbv-meeting","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/2022-international-hbv-meeting\/","title":{"rendered":"2022 International HBV Meeting"},"content":{"rendered":"<p>18-22 Septembre, 2022<br \/>\nParis, France.<\/p>\n<p>Â鶹Æƽâ°æ a sponsoris\u00e9 et particip\u00e9 \u00e0 l&#8217;International HBV Meeting du 18 au 22 septembre 2022 organis\u00e9e par notre collaborateur le Dr David Durantel, Directeur de Recherche en Infectiologie et chef d&#8217;\u00e9quipe au Centre International de Recherche en Infectiologie (CIRI-INSERM), Lyon, France.<br \/>\n<a href=\"https:\/\/www.hbvmeeting.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.hbvmeeting.org\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>18-22 Septembre, 2022<br \/>\nParis, France.<\/p>\n<p>Â鶹Æƽâ°æ a sponsoris\u00e9 et particip\u00e9 \u00e0 l&#8217;International HBV Meeting du 18 au 22 septembre 2022 organis\u00e9e par notre collaborateur le Dr David Durantel, Directeur de Recherche en Infectiologie et chef d&#8217;\u00e9quipe au Centre International de Recherche en Infectiologie (CIRI-INSERM), Lyon, France.<br \/>\n<a href=\"https:\/\/www.hbvmeeting.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.hbvmeeting.org\/<\/a><\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/2022-international-hbv-meeting\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-4224","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/events-fr\/\" rel=\"category tag\">\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"18-22 Septembre, 2022 Paris, France. Â鶹Æƽâ°æ a sponsoris\u00e9 et particip\u00e9 \u00e0 l&#8217;International HBV Meeting du 18 au 22 septembre 2022 organis\u00e9e par notre collaborateur le Dr David Durantel, Directeur de Recherche en Infectiologie et chef d&#8217;\u00e9quipe au Centre International de Recherche en Infectiologie (CIRI-INSERM), Lyon, France. https:\/\/www.hbvmeeting.org\/Lire la suite&nbsp;&raquo;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4224"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4224\/revisions"}],"predecessor-version":[{"id":4226,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4224\/revisions\/4226"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}